Edition:
United States

Omeros Corp (OMER.OQ)

OMER.OQ on NASDAQ Stock Exchange Global Market

16.30USD
25 May 2017
Change (% chg)

$0.21 (+1.31%)
Prev Close
$16.09
Open
$16.18
Day's High
$16.42
Day's Low
$16.18
Volume
14,495
Avg. Vol
129,541
52-wk High
$17.19
52-wk Low
$7.20

OMER.OQ

Chart for OMER.OQ

About

Omeros Corporation is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing small-molecule and protein therapeutics for large-market, as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system. Its marketed drug product, Omidria... (more)

Overall

Beta: 3.46
Market Cap(Mil.): $706.99
Shares Outstanding(Mil.): 43.94
Dividend: --
Yield (%): --

Financials

  OMER.OQ Industry Sector
P/E (TTM): -- 138.86 17.42
EPS (TTM): -1.46 -- --
ROI: -204.72 2.17 -5.45
ROE: -- 0.04 -4.73

BRIEF-Omeros completes IGA nephropathy cohort in OMS721 phase 2 clinical trial

* Omeros announces completion of IGA nephropathy cohort in OMS721 phase 2 clinical trial

May 17 2017

BRIEF-Omeros reports Q1 revenue $12.3 million

* Omeros Corporation reports first quarter 2017 financial results

May 10 2017

BRIEF-Omeros reports more positive data in OMS721 phase 2 trial in renal diseases

* Omeros reports more positive data in OMS721 phase 2 trial in renal diseases

Mar 30 2017

BRIEF-Omeros reports additional positive results from OMS721 Phase 2 trial

* Omeros reports additional positive results from OMS721 phase 2 trial in patients with stem cell transplant-associated thrombotic microangiopathy

Mar 01 2017

More From Around the Web

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $126.79 -0.72
Novartis AG (NOVN.S) CHF79.10 +0.05
Pfizer Inc. (PFE.N) $32.01 -0.05
Roche Holding Ltd. (ROG.S) CHF267.20 -0.70
Roche Holding Ltd. (RO.S) CHF267.50 +0.25
Merck & Co., Inc. (MRK.N) $64.74 -0.19
Bayer AG (BAYGn.DE) €116.90 -0.75
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €87.38 -0.22
Eli Lilly and Co (LLY.N) $77.96 0.00

Earnings vs. Estimates